Cargando…
Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?
A number of immune regulatory cellular therapies, including regulatory T cells and mesenchymal stromal cells, have emerged as novel alternative therapies for the control of transplant alloresponses. Clinical studies have demonstrated their feasibility and safety, however developing our understanding...
Autores principales: | Stark, Helen L., Wang, Hayson C., Kuburic, Jasmina, Alzhrani, Alaa, Hester, Joanna, Issa, Fadi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027493/ https://www.ncbi.nlm.nih.gov/pubmed/33841448 http://dx.doi.org/10.3389/fimmu.2021.664244 |
Ejemplares similares
-
Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use
por: Alzhrani, Alaa, et al.
Publicado: (2020) -
Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients
por: Bottomley, Matthew J., et al.
Publicado: (2022) -
Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation
por: Dieterlen, Maja-Theresa, et al.
Publicado: (2021) -
Advanced Flow Cytometry Assays for Immune Monitoring of CAR-T Cell Applications
por: Blache, Ulrich, et al.
Publicado: (2021) -
Transiently Activated Human Regulatory T Cells Upregulate BCL-XL Expression and Acquire a Functional Advantage in vivo
por: Issa, Fadi, et al.
Publicado: (2019)